Avid Bioservices Inc (CDMO)

[cjgaddy]

Bidrite, the 10-15-14 Ebola PR was not oddly-timed or puff, imo…

You #205760: “it does not explain oddly timed PR's...the Ebola puff piece just before ASM.”

If was not oddly-timed at all. The PS/Ebola article was submitted to The Journal of Immunology Research on Feb25 2014, accepted BY THEM on OCT9 2014, and PR’d by Peregrine on OCT15 2014.

= = = = = = = = = = = =
“PGN401(Bavi) binds to Ebola Virus” article accepted for inclusion in special ed. of Journal of Immunology Research on 10-9-14 and PR’d by Peregrine 10-15-14 (orig. submitted by Peregrine & Public Health England scientists on 2-25-2014…
- - - - - - - - - - - - - - - -
Research Article: “Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions”

Public Health England/PPHM Article on PS/Ebola in the Journal of Immunology Research:
• Submitted: 2-25-2014
• Accepted: 9-3-2014 (as standalone article)
• Accepted: 10-9-2014 (for “Vaccines & Therapies for Biodefense Agents” special ed.)
• PPHM PR: 10-15-2014 ”…publication of a peer-reviewed manuscript related to preclinical research demonstrating that the company's lead drug candidate bavituximab, a phosphatidylserine (PS)-targeting antibody, exhibits specific and strong binding to Ebola virions and Ebola virus (EBOV)-infected cells in vitro. These results will appear in the ‘Vaccines and Therapies for Biodefense Agents’ special edition of the peer-reviewed Journal of Immunology Research in a manuscript titled: "Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions"

Journal of Immunology Research ArticleID 537319
Vaccines & Therapies for Biodefense Agents” (Special Issue)
Rec: 10-9-14; Acc: 10-9-14
http://www.hindawi.com/journals/jir/aa/537319/

10-15-14: Public-Health-England/PPHM article on Bavi/Ebola in Hindawi’s Jrnl-of-Immunology-Res http://tinyurl.com/mg3va35 (also see: http://tinyurl.com/ofa5zlt )